These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23488779)

  • 1. Synthesis and in-vitro antimicrobial evaluation of a high-affinity iron chelator in combination with chloramphenicol.
    Zhu CF; Qiu DH; Kong XL; Hider RC; Zhou T
    J Pharm Pharmacol; 2013 Apr; 65(4):512-20. PubMed ID: 23488779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains.
    Zhou YJ; Liu MS; Osamah AR; Kong XL; Alsam S; Battah S; Xie YY; Hider RC; Zhou T
    Eur J Med Chem; 2015 Apr; 94():8-21. PubMed ID: 25747496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and antimicrobial evaluation of hexadentate hydroxypyridinones with high iron(III) affinity.
    Zhang MX; Zhu CF; Zhou YJ; Kong XL; Hider RC; Zhou T
    Chem Biol Drug Des; 2014 Dec; 84(6):659-68. PubMed ID: 24890019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterization.
    Zhou T; Liu ZD; Neubert H; Kong XL; Ma YM; Hider RC
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5007-11. PubMed ID: 16153843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, iron binding and antimicrobial properties of hexadentate 3-hydroxypyridinones-terminated dendrimers.
    Zhou T; Chen K; Kong LM; Liu MS; Ma YM; Xie YY; Hider RC
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2504-2512. PubMed ID: 29886020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties.
    Nunes A; Podinovskaia M; Leite A; Gameiro P; Zhou T; Ma Y; Kong X; Schaible UE; Hider RC; Rangel M
    J Biol Inorg Chem; 2010 Aug; 15(6):861-77. PubMed ID: 20364296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, iron(III)-binding affinity and in vitro evaluation of 3-hydroxypyridin-4-one hexadentate ligands as potential antimicrobial agents.
    Xu B; Kong XL; Zhou T; Qiu DH; Chen YL; Liu MS; Yang RH; Hider RC
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6376-80. PubMed ID: 21937227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.
    Liu ZD; Khodr HH; Liu DY; Lu SL; Hider RC
    J Med Chem; 1999 Nov; 42(23):4814-23. PubMed ID: 10579844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhodamine labeling of 3-hydroxy-4-pyridinone iron chelators is an important contribution to target Mycobacterium avium infection.
    Moniz T; Nunes A; Silva AM; Queirós C; Ivanova G; Gomes MS; Rangel M
    J Inorg Biochem; 2013 Apr; 121():156-66. PubMed ID: 23384853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of linkages between 1-hydroxy-2(1H)-pyridinone coordinating groups and a tris(2-aminoethyl)amine core in a novel series of synthetic hexadentate iron(III) chelators on antimicrobial activity.
    Workman DG; Hunter M; Wang S; Brandel J; Hubscher V; Dover LG; Tétard D
    Bioorg Chem; 2020 Jan; 95():103465. PubMed ID: 31855824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators.
    Moridani MY; Tilbrook GS; Khodr HH; Hider RC
    J Pharm Pharmacol; 2002 Mar; 54(3):349-64. PubMed ID: 11902801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin.
    Zhou YJ; Zhang MX; Hider RC; Zhou T
    FEMS Microbiol Lett; 2014 Jun; 355(2):124-30. PubMed ID: 24813898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.
    Liu ZD; Kayyali R; Hider RC; Porter JB; Theobald AE
    J Med Chem; 2002 Jan; 45(3):631-9. PubMed ID: 11806714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of iron chelators: syntheses and iron (III) complexing abilities of tripodal tris-bidentate ligands.
    d'Hardemare Adu M; Torelli S; Serratrice G; Pierre JL
    Biometals; 2006 Aug; 19(4):349-66. PubMed ID: 16841245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents.
    Workman DG; Hunter M; Dover LG; Tétard D
    J Inorg Biochem; 2016 Jul; 160():49-58. PubMed ID: 27118028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and properties of novel iron(III)-specific fluorescent probes.
    Luo W; Ma YM; Quinn PJ; Hider RC; Liu ZD
    J Pharm Pharmacol; 2004 Apr; 56(4):529-36. PubMed ID: 15099448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterizations of pyridazine-based iron chelators.
    Ma Y; Kong X; Chen YL; Hider RC
    Dalton Trans; 2014 Dec; 43(45):17120-8. PubMed ID: 25311299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD; Evans RW; Evans PJ; Hider RC
    Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers.
    Zhou T; Kong XL; Liu ZD; Liu DY; Hider RC
    Biomacromolecules; 2008 May; 9(5):1372-80. PubMed ID: 18373358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogue.
    Yokel RA; Fredenburg AM; Durbin PW; Xu J; Rayens MK; Raymond KN
    J Pharm Sci; 2000 Apr; 89(4):545-55. PubMed ID: 10737916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.